NO20005697L - Compounds from Moraxella Catarrhalis - Google Patents
Compounds from Moraxella CatarrhalisInfo
- Publication number
- NO20005697L NO20005697L NO20005697A NO20005697A NO20005697L NO 20005697 L NO20005697 L NO 20005697L NO 20005697 A NO20005697 A NO 20005697A NO 20005697 A NO20005697 A NO 20005697A NO 20005697 L NO20005697 L NO 20005697L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- moraxella catarrhalis
- polypeptides
- basb020
- prophylactic
- Prior art date
Links
- 241000588655 Moraxella catarrhalis Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Abstract
The invention provides BASB020 polypeptides and polynucleotides encoding BASB020 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810285.8A GB9810285D0 (en) | 1998-05-13 | 1998-05-13 | Novel compounds |
| PCT/EP1999/003257 WO1999058684A2 (en) | 1998-05-13 | 1999-05-07 | Compounds from moraxella catarrhalis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20005697D0 NO20005697D0 (en) | 2000-11-10 |
| NO20005697L true NO20005697L (en) | 2001-01-10 |
| NO330169B1 NO330169B1 (en) | 2011-02-28 |
Family
ID=10831997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005697A NO330169B1 (en) | 1998-05-13 | 2000-11-10 | Isolated polypeptide, immunogenic fragment, fusion protein from Moraxella catarrhalis, method of preparation, expression vector, expression system, recombinant organism, host cell, vaccine composition, antibody to the polypeptide and use of the polypeptide |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7122197B1 (en) |
| EP (1) | EP1078064B1 (en) |
| JP (1) | JP4503175B2 (en) |
| KR (1) | KR100610448B1 (en) |
| CN (3) | CN1210401C (en) |
| AT (1) | ATE303442T1 (en) |
| AU (1) | AU737196B2 (en) |
| BR (1) | BR9911773A (en) |
| CA (1) | CA2328502A1 (en) |
| CZ (1) | CZ298227B6 (en) |
| DE (1) | DE69927017T2 (en) |
| DK (1) | DK1078064T3 (en) |
| ES (1) | ES2247803T3 (en) |
| GB (1) | GB9810285D0 (en) |
| HK (1) | HK1036299A1 (en) |
| HU (1) | HUP0102853A3 (en) |
| IL (2) | IL139612A0 (en) |
| NO (1) | NO330169B1 (en) |
| NZ (1) | NZ508322A (en) |
| PL (1) | PL199497B1 (en) |
| TR (1) | TR200003345T2 (en) |
| WO (1) | WO1999058684A2 (en) |
| ZA (1) | ZA200006522B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| CA2493124C (en) | 2002-08-02 | 2014-04-29 | Glaxosmithkline Biologicals S.A. | Vaccine |
| TWI457133B (en) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | Novel composition |
| CN111003884B (en) * | 2019-12-05 | 2021-12-31 | 浙江海洋大学 | Heavy metal sewage treatment equipment and treatment method |
| CN114703214A (en) * | 2022-03-03 | 2022-07-05 | 南京吉芮康生物科技研究院有限公司 | Novel loss-resistant spatiotemporal controllable expression plasmid and application thereof |
| WO2024017827A1 (en) | 2022-07-19 | 2024-01-25 | Glaxosmithkline Biologicals Sa | Continuous process for vaccine production |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552146A (en) | 1991-08-15 | 1996-09-03 | Board Of Regents, The University Of Texas System | Methods and compositions relating to useful antigens of Moraxella catarrhalis |
| US5712118A (en) * | 1993-09-29 | 1998-01-27 | Research Foundation Of State University Of New York | Vaccine for branhamella catarrhalis |
| US6440425B1 (en) * | 1995-05-01 | 2002-08-27 | Aventis Pasteur Limited | High molecular weight major outer membrane protein of moraxella |
| US6607731B1 (en) * | 1995-09-22 | 2003-08-19 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| US6090576A (en) * | 1996-03-08 | 2000-07-18 | Connaught Laboratories Limited | DNA encoding a transferrin receptor of Moraxella |
| US7341727B1 (en) | 1996-05-03 | 2008-03-11 | Emergent Product Development Gaithersburg Inc. | M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same |
| WO1998006851A2 (en) | 1996-08-12 | 1998-02-19 | Board Of Regents, The University Of Texas System | DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS) |
| US6673910B1 (en) | 1999-04-08 | 2004-01-06 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics |
| EP1218512A2 (en) | 1999-06-18 | 2002-07-03 | Elitra Pharmaceuticals, Inc. | Nucleotide sequences of moraxella catarrhalis genome |
-
1998
- 1998-05-13 GB GBGB9810285.8A patent/GB9810285D0/en not_active Ceased
-
1999
- 1999-05-07 WO PCT/EP1999/003257 patent/WO1999058684A2/en active IP Right Grant
- 1999-05-07 CN CNB998085545A patent/CN1210401C/en not_active Expired - Fee Related
- 1999-05-07 CN CNA2006100997400A patent/CN1876679A/en active Pending
- 1999-05-07 IL IL13961299A patent/IL139612A0/en active IP Right Grant
- 1999-05-07 CA CA002328502A patent/CA2328502A1/en not_active Abandoned
- 1999-05-07 AT AT99924948T patent/ATE303442T1/en active
- 1999-05-07 ES ES99924948T patent/ES2247803T3/en not_active Expired - Lifetime
- 1999-05-07 US US09/700,228 patent/US7122197B1/en not_active Expired - Fee Related
- 1999-05-07 BR BR9911773-8A patent/BR9911773A/en not_active Application Discontinuation
- 1999-05-07 EP EP99924948A patent/EP1078064B1/en not_active Expired - Lifetime
- 1999-05-07 TR TR2000/03345T patent/TR200003345T2/en unknown
- 1999-05-07 JP JP2000548475A patent/JP4503175B2/en not_active Expired - Fee Related
- 1999-05-07 DK DK99924948T patent/DK1078064T3/en active
- 1999-05-07 CZ CZ20004203A patent/CZ298227B6/en not_active IP Right Cessation
- 1999-05-07 HU HU0102853A patent/HUP0102853A3/en unknown
- 1999-05-07 CN CNB2005100746588A patent/CN100484956C/en not_active Expired - Fee Related
- 1999-05-07 PL PL344792A patent/PL199497B1/en not_active IP Right Cessation
- 1999-05-07 AU AU41421/99A patent/AU737196B2/en not_active Ceased
- 1999-05-07 KR KR1020007012705A patent/KR100610448B1/en not_active IP Right Cessation
- 1999-05-07 NZ NZ508322A patent/NZ508322A/en unknown
- 1999-05-07 DE DE69927017T patent/DE69927017T2/en not_active Expired - Lifetime
-
2000
- 2000-11-10 NO NO20005697A patent/NO330169B1/en not_active IP Right Cessation
- 2000-11-10 IL IL139612A patent/IL139612A/en not_active IP Right Cessation
- 2000-11-10 ZA ZA200006522A patent/ZA200006522B/en unknown
-
2001
- 2001-08-13 HK HK01105646A patent/HK1036299A1/en not_active IP Right Cessation
-
2006
- 2006-02-28 US US11/364,212 patent/US20060147462A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1078064T3 (en) | Compounds from moraxella catarrhalis | |
| DE69921649D1 (en) | MORAXELLA CATARRHALIS PILQ PROTEINE | |
| DE69928931D1 (en) | MORAXELLA CATARRHALIS POLYNUCLEOTIDES AND POLYPEPTIDES | |
| PL345193A1 (en) | Basb027 proteins and genes from moraxella catarrhalis | |
| ATE397666T1 (en) | NEW COMPOUNDS FROM MORAXELLA CATARRHALIS | |
| ATE454452T1 (en) | BASB118 POLYPEPTIDE AND POLYNUCLEOTIDE FROM MORAXELLA CATARRHALIS | |
| ATE274582T1 (en) | BASB028 POLYPEPTIDES AND POLYNUCLEOTIDES CODING THEREFOR FROM MORAXELLA CATARRHALIS | |
| DK1204752T3 (en) | Immunogenic polypeptides derived from Moraxella catarrhalis and their applications | |
| WO1999058682A3 (en) | Compounds from moraxella catarrhalis | |
| ATE293693T1 (en) | MORAXELLA CATARRHALIS ANTIGEN BASB117 | |
| DE60034463D1 (en) | BASB119 POLYPEPTIDE AND POLYNUCLEOTIDE FROM MORAXELLA CATARRHALIS | |
| DK1196586T3 (en) | BASB111 polypeptide and polynucleotide from Moraxella catharralis | |
| DE60019613D1 (en) | MORAXELLA CATARRHALIS ANTIGEN BASB120 | |
| ATE368686T1 (en) | POLYPEPTIDES FROM MORAXELLA (BRANHAMELLA) CATARRHALIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |